Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04759443 · ClinicalTrials.gov registry record

Detection of Small Fiber Neuropathy Using Skin Properties

A clinical trial of Small Fiber Neuropathy, sponsored by Brigham and Women's Hospital.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT04759443: Recruiting study of Small Fiber Neuropathy, sponsored by Brigham and Women's Hospital.

NCT04759443 is a study of Small Fiber Neuropathy that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04759443, a study of Small Fiber Neuropathy, is actively recruiting participants, sponsored by Brigham and Women's Hospital.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

Small fiber neuropathy affects millions of peoples worldwide. The neuropathy is causing disabling burning pain and dysautonomia such as dizziness with standing, brain fog, fatigue, constipation, too much or too little sweating. The detection of nerve damage is complicated and not widely available; it requires either skin biopsy or specialized equipment and training. This project utilizes the mathematical processing of skin pictures for the purpose to extract the statistical features related to loss of small fibers. This approach can improve the availability of diagnosis of small fiber neuropathy.

Primary Outcome

The diagnostic accuracy of image processing will be evaluated by using the skin biopsy as a reference.

Conditions Studied

Interventions

  • OTHER Image processing of skin

Study Locations (1)

Massachusetts

  • Brigham and Women's Faulkner Hospital - Boston

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2021-07-01
Est. Completion 2027-02-01
Brigham and Women's Hospital

937 total trials

What NCT04759443 shows while recruiting

NCT04759443 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Small Fiber Neuropathy appearing as the primary indexed condition, and to 1 intervention - of which Image processing of skin is the first listed.

NCT04759443 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04759443 about?

NCT04759443 is a clinical study titled "Detection of Small Fiber Neuropathy Using Skin Properties". Small fiber neuropathy affects millions of peoples worldwide. The neuropathy is causing disabling burning pain and dysautonomia such as dizziness with standing, brain fog, fatigue, constipation, too much or too little sweating. The detection of nerve damage is complicated and not widely available; i...

What is the current status of trial NCT04759443?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2021-07-01. Estimated completion is 2027-02-01.

What conditions does trial NCT04759443 study?

This clinical trial studies the following conditions: Small Fiber Neuropathy.

What interventions are being tested in trial NCT04759443?

The interventions under investigation include: Image processing of skin (OTHER).

Who is sponsoring clinical trial NCT04759443?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04759443 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Small Fiber Neuropathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04759443, the US trial registry maintained by the National Library of Medicine. NCT04759443 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.